Paracelsian Inc (PRLN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John H. Farro who wrote (3608)	5/9/1998 2:39:00 PM
From: Hank	of 4342

Robin, You are correct that the current clinical data on AndroCar is insufficient to gain financial support from big pharma. That would require full scale clinical trials. I doubt any data was collected at all in the second trial because of lack of funds. Doing full scale clinical trials requires big bucks and the money from the secondary may not be enough for that unless the price can get a sustained boost back to the $2 level. It depends on how many new employees they may have to hire and what additional lab equipment they may have to purchase ( remember they supposedly sold some off last year to make ends meat). Even then, promising phase I and phase II trials may have to be completed first before big drug money is convinced they are worth investing in. In some cases, I have seen big drug companies withhold their financial support until phase III trials are completed. This puts a tremendous financial burden on PRLN to prove themselves and absolutely necessitates the generation of capital through other avenues such as the sale of herbal extracts as dietary supplements. I would be extremely surprised to see PRLN get funding from a big drug company any time within the next several years. Hank

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next